Administer orally with or without food. Use a measuring spoon or cup for accurate dosing.

Dextromethorphan acts centrally on the cough center in the medulla to elevate the cough threshold. Phenylephrine is an alpha-1 adrenergic agonist that causes vasoconstriction in the nasal mucosa, thereby reducing swelling and congestion. Chlorpheniramine maleate is a first-generation antihistamine that competitively blocks H1 receptors, reducing allergic symptoms like sneezing and runny nose.

• •Hypersensitivity to any component of the formulation.
• •Patients receiving monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy.
• •Severe hypertension or coronary artery disease.
• •Narrow-angle glaucoma, urinary retention.

Store below 30°C in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.

Symptoms of overdose may include severe drowsiness, dizziness, nausea, vomiting, rapid heartbeat, hypertension, hallucinations, and seizures. Management involves supportive care, gastric lavage if recent ingestion, and symptomatic treatment. Naloxone may be considered for severe dextromethorphan toxicity.

Pregnancy Category C. Use only if potential benefit outweighs potential risk to the fetus. Not recommended during breastfeeding as components may pass into breast milk and cause adverse effects in infants. Consult a doctor before use.